| 产品描述: | LY2444296 是一种有口服生物活性、高亲和力、选择性的短效的 KOPR 拮抗剂,其 Ki 值为 ~1 nM。LY2444296 具有抗焦虑样的作用。 |
| 靶点: |
Ki: ~1 nM (KOPR);OpioidReceptor |
| 体内研究: |
LY2444296 displays anti-anxiety like effects in the EPM test. LY2444296 (3 mg/kg; i.p.; 30 min before U69,593 administration) prevents behavioral and neuroendocrine effects caused by the reference kappa agonist U69,593 in cocaine-naïve rats. LY2444296 reduces anxiety-like and depressive-like behaviors, as well as CORT release, in rats tested after chronic extended access cocaine self-administration, but not in cocaine-naïve rats. |
| 参考文献: |
1. Huang P, et al. Two short-acting kappa opioid receptor antagonists (zyklophin and LY2444296) exhibited different behavioral effects from the long-acting antagonist norbinaltorphimine in mouse anxiety tests. Neurosci Lett. 2016 Feb 26;615:15-20.
2.Valenza M, et al. "Effects of the novel relatively short-acting kappa opioid receptor antagonist LY2444296 in behaviors observed after chronic extended-access cocaine self-administration in rats". Psychopharmacology (Berl). 2017 Aug;234(15):2219-2231. |
| 溶解性: |
Soluble in ethanol |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.448 ml |
12.242 ml |
24.483 ml |
| 5 mM |
0.49 ml |
2.448 ml |
4.897 ml |
| 10 mM |
0.245 ml |
1.224 ml |
2.448 ml |
| 50 mM |
0.049 ml |
0.245 ml |
0.49 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |